Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells

Gastroenterology

Volumn 123, Issue 3, 2002, Pages 845-861

  Fischer, Richard ^a   Cariers, Alexandra ^a   Reinehr, Roland ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE 3; CASPASE 8; CASPASE 9; DEXAMETHASONE; FAS ANTIGEN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL TRANSFORMATION; COCULTURE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; MACROPHAGE ACTIVATION; MONOCULTURE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; STELLATE CELL;

EID: 0036724910     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.35384     Document Type: Article

References (43)

1. Signal transduction in hepatic stellate cells
2. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
3. The biology of liver fibrogenesis - An imbalance of proliferation, growth arrest and apoptosis of myofibroblasts
4. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin-1
5. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
6. 4-induced fibrotic rat livers
7. Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis
8. Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (Ito cells)
9. Hepatic lipocytes: The principle collagen-producing cells of normal rat liver
10. CD95/CD95L-mediated apoptosis of the hepatic stellate cell
11. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells
12. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand
13. Transforming growth factor β and tumor necrosis factor α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
14. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats
15. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis
16. Identification and characterization of a new member of the TNF family that induces apoptosis
17. The CD95 (APO-1/Fas) and the TRAIL (Apo-2L) apoptosis systems
18. The TRAIL to selective tumor death
19. Lipopolysaccharide induces expression of AP02 ligand/TRAIL in human monocytes and macrophages
20. Monocyte-mediated tumoricidal activity via the tumor necrosis factor related cytokine, TRAIL
21. Surface expression of TRAIL/APO-2 ligand in activated mouse T and B cells
22. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
23. The death domain kinase RIP is essential for TRAIL (Apo2L)- induced activation of IκB kinase and c-Jun N-terminal kinase
24. Fas triggers an alternative, caspase 8-independent cell death pathway using the RIP kinase as effector molecule
25. An alternative, nonapoptotic form of programmed cell death
26. CD95(APO-1/Fas) ligand expression by liver macrophages (Kupffer cells) contributes to immune privilege in rat liver
27. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and non-parenchymal liver cells
28. Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4
29. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative
30. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation
31. Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
32. Differential inhibition of prostaglandin and superoxide production by dexamethasone in primary cultures of rat Kupffer cells
33. Release of lysosomal enzymes is not correlated with superoxide and prostaglandin production by stimulated rat Kupffer cells in primary culture
34. Mitochondrial permeability transition and oxidative stress
35. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP
36. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages
37. Executioner caspase-3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
38. More than one way to go
39. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation
40. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore
41. The CARD domain: A new apoptotic signaling motif
42. RIP3, a novel apoptosis-inducing kinase
43. The RIP-like kinase, RIP3, induces apoptosis and NF-κB nuclear translocation and localizes to mitochondria